Forbes February 15, 2024
Seth Joseph

As last miles go, medication adherence – when patients take the medication that’s been prescribed to them – is among the toughest. Every link in the drug supply chain can impact adherence, determining whether patients are treating their conditions or not, with two factors standing out: accessibility and cost. Significant criticism and skepticism is being cast upon Pharmacy Benefit Managers (PBMs), as policymakers at state and federal levels and regulatory agencies such as Federal Trade Commission conduct inquiries into the role they play and impact on drug pricing.

The web of parties controlling the prescription value chain, PBMs being at the forefront, have forged a system that routinely inflates the cost of medication beyond reason and have, so far, proven...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease

Share This Article